Show simple item record

dc.contributor.authorMcCabe, Rose
dc.contributor.authorBullenkamp, J
dc.contributor.authorHansson, L
dc.contributor.authorLauber, C
dc.contributor.authorMartinez-Leal, R
dc.contributor.authorRössler, W
dc.contributor.authorSalize, HJ
dc.contributor.authorSvensson, B
dc.contributor.authorTorres-Gonzalez, F
dc.contributor.authorvan den Brink, R
dc.contributor.authorWiersma, D
dc.contributor.authorPriebe, S
dc.date.accessioned2016-02-15T13:47:38Z
dc.date.issued2012-04-27
dc.description.abstractOBJECTIVE: Previous research has shown that a better therapeutic relationship (TR) predicts more positive attitudes towards antipsychotic medication, but did not address whether it is also linked with actual adherence. This study investigated whether the TR is associated with adherence to antipsychotics in patients with schizophrenia. METHODS: 134 clinicians and 507 of their patients with schizophrenia or a related psychotic disorder participated in a European multi-centre study. A logistic regression model examined how the TR as rated by patients and by clinicians is associated with medication adherence, adjusting for clinician clustering and symptom severity. RESULTS: Patient and clinician ratings of the TR were weakly inter-correlated (r(s) = 0.13, p = 0.004), but each was independently linked with better adherence. After adjusting for patient rated TR and symptom severity, each unit increase in clinician rated TR was associated with an increase of the odds ratio of good compliance by 65.9% (95% CI: 34.6% to 104.5%). After adjusting for clinician rated TR and symptom severity, for each unit increase in patient rated TR the odds ratio of good compliance was increased by 20.8% (95% CI: 4.4% to 39.8%). CONCLUSIONS: A better TR is associated with better adherence to medication among patients with schizophrenia. Patients' and clinicians' perspectives of the TR are both important, but may reflect distinct aspects.en_GB
dc.description.sponsorshipResearch Directorate of the European Commission within Framework Programme 5en_GB
dc.identifier.citationVol. 7, Iss. 4, pp. e36080 -en_GB
dc.identifier.doi10.1371/journal.pone.0036080
dc.identifier.grantnumberQLG5-CT-2002-01938en_GB
dc.identifier.otherPONE-D-12-03675
dc.identifier.urihttp://hdl.handle.net/10871/19850
dc.language.isoenen_GB
dc.publisherPublic Library of Scienceen_GB
dc.relation.urlhttp://www.ncbi.nlm.nih.gov/pubmed/22558336en_GB
dc.relation.urlhttp://journals.plos.org/plosone/article?id=10.1371/journal.pone.0036080en_GB
dc.rightsCopyright © 2012 McCabe et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.en_GB
dc.subjectAdulten_GB
dc.subjectAntipsychotic Agentsen_GB
dc.subjectDemographyen_GB
dc.subjectFemaleen_GB
dc.subjectHumansen_GB
dc.subjectMaleen_GB
dc.subjectMedication Adherenceen_GB
dc.subjectPhysician-Patient Relationsen_GB
dc.subjectPhysiciansen_GB
dc.subjectProfessional Competenceen_GB
dc.subjectRegression Analysisen_GB
dc.subjectSchizophreniaen_GB
dc.subjectTime Factorsen_GB
dc.subjectTreatment Outcomeen_GB
dc.titleThe therapeutic relationship and adherence to antipsychotic medication in schizophrenia.en_GB
dc.typeArticleen_GB
dc.date.available2016-02-15T13:47:38Z
dc.identifier.issn1932-6203
exeter.place-of-publicationUnited States
dc.descriptionPublisheden_GB
dc.descriptionJournal Articleen_GB
dc.descriptionResearch Support, Non-U.S. Gov'ten_GB
dc.identifier.journalPLoS Oneen_GB


Files in this item

This item appears in the following Collection(s)

Show simple item record